Clinical Trial Update: Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of melatonin prolonged-release and clonazepam for REM sleep behavior disorder in Parkinson disease. The study e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• Clonazepam (Clonazepam)
• Melatonin PR (melatonin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: REM Sleep Behavior Disorder, Parkinson Disease | Phase 2 | Status: UNKNOWN